Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation.

Mol Pain

Department of Anesthesiology and Pain Medicine, Division of Anesthesiology and Critical Care Medicine, University of Texas MD Anderson Cancer Center, Unit 409, Houston, TX 77030, USA.

Published: March 2009

Background: Clearance of synaptically released glutamate, and hence termination of glutamatergic neurotransmission, is carried out by glutamate transporters, most especially glutamate transporter-1 (GLT-1) and the glutamate-aspartate transporter (GLAST) that are located in astrocytes. It is becoming increasingly well appreciated that changes in the function and expression of GLT-1 and GLAST occur under different physiological and pathological conditions. Here we investigated the plasticity in expression of GLT-1 and GLAST in the spinal dorsal horn using immunohistochemistry following partial sciatic nerve ligation (PSNL) in rats.

Results: Animals were confirmed to develop hypersensitivity to mechanical stimulation by 7 days following PSNL. Baseline expression of GLT-1 and GLAST in naive animals was only observed in astrocytes and not in either microglia or neurons. Microglia and astrocytes showed evidence of reactivity to the nerve injury when assessed at 7 and 14 days following PSNL evidenced by increased expression of OX-42 and GFAP, respectively. In contrast, the total level of GLT-1 and GLAST protein decreased at both 7 and 14 days after PSNL. Importantly, the cellular location of GLT-1 and GLAST was also altered in response to nerve injury. Whereas activated astrocytes showed a marked decrease in expression of GLT-1 and GLAST, activated microglia showed de novo expression of GLT-1 and GLAST at 7 days after PSNL and this was maintained through day 14. Neurons showed no expression of GLT-1 or GLAST at any time point.

Conclusion: These results indicate that the expression of glutamate transporters in astrocytes and microglia are differentially regulated following nerve injury.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676254PMC
http://dx.doi.org/10.1186/1744-8069-5-15DOI Listing

Publication Analysis

Top Keywords

glt-1 glast
36
expression glt-1
24
days psnl
16
glutamate transporters
12
nerve injury
12
glt-1
10
glast
10
plasticity expression
8
expression glutamate
8
glast spinal
8

Similar Publications

Anxiety is a prominent non-motor symptom of Parkinson's disease (PD). Changes in the B-spectrum recordings in PD patients of the prefrontal cortex correlate with increased anxiety. Using a rodent model of PD, we reported alterations in glutamate synapses in the striatum and substantia nigra following dopamine (DA) loss.

View Article and Find Full Text PDF

The glutamatergic system, located throughout the brain including the prefrontal cortex and nucleus accumbens, plays a critical role in reward and reinforcement processing, and mediates the psychotropic effects of addictive drugs such as cocaine. Glutamate transporters, including EAAT2/GLT-1, are responsible for removing glutamate from the synaptic cleft. Reduced expression of GLT-1 following chronic cocaine use and abstinence has been reported.

View Article and Find Full Text PDF

Glutamate, the primary excitatory neurotransmitter in the CNS, is regulated by the excitatory amino acid transporters (EAATs) GLT-1 and GLAST. Following traumatic brain injury (TBI), extracellular glutamate levels increase, contributing to excitotoxicity, circuit dysfunction, and morbidity. Increased neuronal glutamate release and compromised astrocyte-mediated uptake contribute to elevated glutamate, but the mechanistic and spatiotemporal underpinnings of these changes are not well established.

View Article and Find Full Text PDF
Article Synopsis
  • * This study investigates the effects of different doses of leptin on cerebral ischemia-reperfusion injury in mice, assessing its neuroprotective capabilities after a simulated stroke event.
  • * Results indicated that leptin treatment improved neurological function, reduced brain damage, and altered the expression of certain proteins and glutamate levels, suggesting that leptin may protect the brain by mitigating excitotoxicity from excess glutamate.
View Article and Find Full Text PDF

NRICM101 prevents kainic acid-induced seizures in rats by modulating neuroinflammation and the glutamatergic system.

Int Immunopharmacol

October 2024

School of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan; Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan City 33303, Taiwan. Electronic address:

Article Synopsis
  • The study investigates the effects of the Traditional Chinese medicine formula NRICM101 on epilepsy, specifically its ability to reduce seizures induced by kainic acid (KA) in rats.
  • NRICM101 significantly decreases seizure behavior, neuronal loss, and glutamate levels while enhancing protective proteins in the brain, and its effects are comparable to the established antiseizure drug carbamazepine.
  • The formula also shows promising neuroprotective effects by mitigating inflammation and cell death in the brain without causing harm to the liver or kidneys, suggesting its potential for managing epilepsy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!